Homocysteine stimulates monocyte chemoattractant protein-1 expression in the kidney via nuclear factor-κB activation

American Journal of Physiology - Renal Physiology

Volumn 294, Issue 1, 2008, Pages

  Hwang, Sun Young ^a,b   Woo, Connie W H ^a,b   Au Yeung, Kathy K W ^b   Siow, Yaw L ^a,b   Zhu, Tong Y ^b   O, Karmin ^a,b,c  

^a UNIVERSITY OF MANITOBA   (Canada)

^b The Inst of Cardiovascular Sciences   (Canada)

^c ST BONIFACE GENERAL HOSPITAL   (Canada)

Author keywords

Hyperhomocysteinemia

Indexed keywords

HOMOCYSTEINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; METHIONINE; MONOCYTE CHEMOTACTIC PROTEIN 1; OLIGODEOXYNUCLEOTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; GENE EXPRESSION; HUMAN; HUMAN CELL; HYPERHOMOCYSTEINEMIA; KIDNEY INJURY; KIDNEY PROXIMAL TUBULE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION;

EID: 38349181044     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00331.2007     Document Type: Article

References (40)

1. Anders HJ, Vielhauer V, Kretzler M, Cohen CD, Segerer S, Luckow B, Weller L, Grone HJ, Schlondorff D. Chemokine and chemokine receptor expression during initiation and resolution of immune complex glomerulonephritis. J Am Soc Nephrol 12: 919-931, 2001.
2. Au-Yeung KK, Woo CW, Sung FL, Yip JC, Siow YL, O K. Hyperhomocysteinemia activates nuclear factor-κB in endothelial cells via oxidative stress. Circ Res 94: 28-36, 2004.
3. Baldwin AS Jr. The NF-κB and IκB proteins: new discoveries and insights. Annu Rev Immunol 14: 649-683, 1996.
4. Brand K, Page S, Rogler G, Bartsch A, Brandl R, Knuechel R, Page M, Kaltschmidt C, Baeuerle PA, Neumeier D. Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion. J Clin Invest 97: 1715-1722, 1996.
5. Chatterjee PK, Cuzzocrea S, Brown PA, Zacharowski K, Stewart KN, Mota-Filipe H, Thiemermann C. Tempol, a membrane-permeable radical scavenger, reduces oxidant stress-mediated renal dysfunction and injury in the rat. Kidney Int 58: 658-673, 2000.
6. Choy PC, Siow YL, Mymin D, O K. Lipids and atherosclerosis. Biochem Cell Biol 82: 212-224, 2004.
7. Clarke R, Daly L, Robinson K, Naughten E, Cahalane S, Fowler B, Graham I. Hyperhomocysteinemia: an independent risk factor for vascular disease. N Engl J Med 324: 1149-1155, 1991.
8. Grandaliano G, Gesualdo L, Ranieri E, Monno R, Stallone G, Schena FP. Monocyte chemotactic peptide-1 expression and monocyte infiltration in acute renal transplant rejection. Transplantation 63: 414-420, 1997.
9. Karin M. The beginning of the end: IκB kinase (IKK) and NF-κB activation. J Biol Chem 274: 27339-27342, 1999.
10. Kumagai H, Katoh S, Hirosawa K, Kimura M, Hishida A, Ikegaya N. Renal tubulointerstitial injury in weanling rats with hyperhomocysteinemia. Kidney Int 62: 1219-1228, 2002.
11. Kuusniemi AM, Lapatto R, Holmberg C, Karikoski R, Rapola J, Jalanko H. Kidneys with heavy proteinuria show fibrosis, inflammation, and oxidative stress, but no tubular phenotypic change. Kidney Int 68: 121-132, 2005.
12. Li N, Chen YF, Zou AP. Implications of hyperhomocysteinemia in glomerular sclerosis in hypertension. Hypertension 39: 443-448, 2002.
13. -ΔΔCt method. Methods 25: 402-408, 2001.
14. Lynn EG, Siow YL, Frohlich J, Cheung GT, O K. Lipoprotein-X stimulates monocyte chemoattractant protein-1 expression in mesangial cells via nuclear factor-κB. Kidney Int 60: 520-532, 2001.
15. Lynn EG, Siow YL, OK. Very low-density lipoprotein stimulates the expression of monocyte chemoattractant protein-1 in mesangial cells. Kidney Int 57: 1472-1483, 2000.
16. Marumo T, Schini-Kerth VB, Fisslthaler B, Busse R. Platelet-derived growth factor-stimulated superoxide anion production modulates activation of transcription factor NF-κB and expression of monocyte chemoattractant protein 1 in human aortic smooth muscle cells. Circulation 96: 2361-2367, 1997.
17. McCully KS. Homocysteine and vascular disease. Nat Med 2: 386-389, 1996.
18. Mercurio F, Zhu H, Murray BW, Shevchenko A, Bennett BL, Li J, Young DB, Barbosa M, Mann M, Manning A, Rao A. IKK-1 and IKK-2: cytokine-activated IκB kinases essential for NF-κB activation. Science 278: 860-866, 1997.
19. Mudd SH, Finkelstein JD, Refsum H, Ueland PM, Malinow MR, Lentz SR, Jacobsen DW, Brattstrom L, Wilcken B, Wilcken DE, Blom HJ, Stabler SP, Allen RH, Selhub J, Rosenberg IH. Homocysteine and its disulfide derivatives: a suggested consensus terminology. Arterioscler Thromb Vasc Biol 20: 1704-1706, 2000.
20. Ninomiya T, Kiyohara Y, Kubo M, Tanizaki Y, Tanaka K, Okubo K, Nakamura H, Hata J, Oishi Y, Kato I, Hirakata H, Iida M. Hyperhomocysteinemia and the development of chronic kidney disease in a general population: the Hisayama study. Am J Kidney Dis 44: 437-445, 2004.
21. Nygard O, Nordrehaug JE, Refsum H, Ueland PM, Farstad M, Vollset SE. Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med 337: 230-236, 1997.
22. O K, Siow YL. Biochemical mechanisms of hyperhomocysteinemia in atherosclerosis: role of chemokine expression In: Atherosclerosis, Hypertension and Diabetes, edited by Pierce GN, Nagano M, Zahradka P, and Dhalla NS. Boston, MA: Kluwer Academic, 2003.
23. Prathapasinghe GA, Siow YL, O K. Detrimental role of homocysteine in renal ischemia-reperfusion injury. Am J Physiol Renal Physiol 292: F1354-F1363, 2007.
24. Prodjosudjadi W, Daha MR, Gerritsma JS, Florijn KW, Barendregt JN, Bruijn JA, van der Woude FJ, van Es LA. Increased urinary excretion of monocyte chemoattractant protein-1 during acute renal allograft rejection. Nephrol Dial Transplant 11: 1096-1103, 1996.
25. Robertson H, Morley AR, Talbot D, Callanan K, Kirby JA. Renal allograft rejection: β-chemokine involvement in the development of tubulitis. Transplantation 69: 684-687, 2000.
26. Rovin BH, Doe N, Tan LC. Monocyte chemoattractant protein-1 levels in patients with glomerular disease. Am J Kidney Dis 27: 640-646, 1996.
27. Schachter AD, Strehlau J, Zurakowski D, Vasconcellos L, Kim YS, Zheng XX, Gunshin Y, Overstreet SL, Benfield MR, Tejani A, Harmon WE, Herrin JT, Strom TB. Increased nuclear factor-κB and angiotensinogen gene expression in posttransplant recurrent focal segmental glomerulosclerosis. Transplantation 70: 1107-1110, 2000.
28. Sekiguchi M, Natori Y, Iyonaga K, Takeya M, Natori Y. Expression of monocyte chemoattractant protein-1 in experimental crescentic glomerulonephritis in rats. J Lab Clin Med 129: 239-244, 1997.
29. Simeonidis S, Stauber D, Chen G, Hendrickson WA, Thanos D. Mechanisms by which IκaB proteins control NF-κB activity. Proc Natl Acad Sci USA 96: 49-54, 1999.
30. Sung FL, Slow YL, Wang G, Lynn EG, O K. Homocysteine stimulates the expression of monocyte chemoattractant protein-1 in endothelial cells leading to enhanced monocyte chemotaxis. Mol Cell Biochem 216: 121-128, 2001.
31. Sung FL, Zhu TY, Au-Yeung KK, Siow YL, O K. Enhanced MCP-1 expression during ischemia/reperfusion injury is mediated by oxidative stress and NF-κB. Kidney Int 62: 1160-1170, 2002.
32. Tang WW, Qi M, Warren JS, Van GY. Chemokine expression in experimental tubulointerstitial nephritis. J Immunol 159: 870-876, 1997.
33. Wang G, Siow YL, O K. Homocysteine induces monocyte chemoattractant protein-1 expression by activating NF-κB in THP-1 macrophages. Am J Physiol Heart Circ Physiol 280: H2840-H2847, 2001.
34. Wang G, Siow YL, O K. Homocysteine stimulates nuclear factor κB activity and monocyte chemoattractant protein-1 expression in vascular smooth-muscle cells: a possible role for protein kinase C. Biochem J 352: 817-826, 2000.
35. Wang G, Woo CW, Sung FL, Siow YL, O K. Increased monocyte adhesion to aortic endothelium in rats with hyperhomocysteinemia: role of chemokine and adhesion molecules. Arterioscler Thromb Vasc Biol 22: 1777-1783, 2002.
36. Wenzel U, Schneider A, Valente AJ, Abboud HE, Thaiss F, Helmchen UM, Stahl RA. Monocyte chemoattractant protein-1 mediates monocyte/ macrophage influx in anti-thymocyte antibody-induced glomerulonephritis. Kidney Int 51: 770-776, 1997.
37. Wheeler DC. Cardiovascular disease in patients with chronic renal failure. Lancet 348: 1673-1674, 1996.
38. Woo CW, Siow YL, O K. Homocysteine activates cAMP-response element binding protein in HepG2 through cAMP/PKA signaling pathway. Arterioscler Thromb Vasc Biol 26: 1043-1050, 2006.
39. Woo CW, Siow YL, Pierce GN, Choy PC, Minuk GY, Mymin D, O K. Hyperhomocysteinemia induces hepatic cholesterol biosynthesis and lipid accumulation via activation of transcription factors. Am J Physiol Endocrinol Metab 288: E1002-E1010, 2005.
40. Zhang F, Siow YL, O K. Hyperhomocysteinemia activates NF-κB and inducible nitric oxide synthase in the kidney. Kidney Int 65: 1327-1338, 2004.